HMPI

Healthcare Systems: Are You Prepared For The Post-COVID-19 Era? (CU Denver, 4/7)

Rulon F. Stacey, Ph.D., FACHE, and Jiban Khuntia, PhD, Director, Assistant Professor, Information Systems and Health Administration, University of Colorado, Denver

Join the related Webinar with the authors on Thursday, April 23, 2020: Leading to Recovery: Planning Priorities for Healthcare Organizations Post-COVID-19. Register here.

1:00 PM – 2:00 PM
Mountain Time

Abstract

Contact: Rulon.Stacey@ucdenver.edu

What is the message? Healthcare systems need to start thinking about initiatives once the COVID-19 crisis ends, both to support financial status and to improve healthcare quality. Three initiatives include readying the ground for FEMA, reducing costs, and embracing digital healthcare.

What is the evidence? The authors draw on experience in healthcare research and management.

Timeline: Submitted April 6, 2020; accepted after revision, April 6, 2020

Cite as: Rulon F. Stacey and Jiban Khuntia, 2020. Healthcare systems: Are you prepared for the post-COVID-19 era? Health Management, Policy and Innovation (HMPI.org), volume 5, Issue 1, special issue on COVID-19, April 2020.

COVID+1: We Need to Think Beyond Our Immediate Needs

The COVID-19 situation leaves the United States health systems and hospitals facing more than just a lack of resources, staff burnout, and corporate anxiety. The financial distress related to margins, revenue, and reimbursements is something absent in the news media and public narrative, yet is coming to a slow but sure boil in the background.

While engaged in the combat against COVID-19, deploying all of their resources, healthcare systems neglect the potential financial distress and preparedness for a COVID + 1, the day after this disaster ends. It is paramount that all health systems and hospitals start preparing immediately for the unavoidable financial challenges that are certain to come by using three tactics: (1) readying the ground for FEMA, (2) reducing cost, and (3) embracing digital healthcare. [i]

Strategies for Immediate Needs

In  discussions with a number of health systems across the nation this week, we found two broad strategies underway to manage the current situation: flattening the curve and increasing capacity.

Flattening the curve: The first is flattening the curve by allocating maximum federal and state resources to the current problem. The nationwide decision for social distancing and lockdowns is centered to achieve that goal.

Increasing capacity: Second, health systems themselves are working to increase supply by finding any way possible to create capacity. This includes tactics such as stopping all elective procedures in their hospital or health system, turning ambulatory surgery suites into ICUs, turning neonatal ICU space into adult ICU beds, and substantially expanding virtual care clinics.

Health systems outside of New York and other COVID-19 hot spots have reported a decrease in inpatient (hospital) volumes and ER visits as patients are fearful to go to the hospital and the staff is burned out and strained due to the extra work needed to use personal protective equipment (PPE) on every single patient. Broadly, all parts of the health delivery system are facing all-time high stress as healthcare professionals find themselves either in the middle of the onslaught or preparing during every waking moment for that potential.

It is beyond doubt that every effort is currently being made to prepare for the worst-case scenario. If every geographic location gets hit with this as hard as New York or Italy, we will certainly be unable to address this as a country. However, if we are able to lower demand for health services (by flattening the curve) while simultaneously increasing the supply (by creating capacity), we will be able to get through the next few months.

The Looming Financial Disaster

We can see the beginning of financial distress already trying to cripple health systems. This leaves the unfortunate reality that with the current structure of the healthcare system, the very best case scenario is that our health system suffers a financial disaster as opposed to the country suffering a medical catastrophe.

Because most health systems in the country are still financially tied to a “fee-for-service” payment model, and because often half of a health system’s revenue is tied to elective and/or outpatient healthcare, such a financial disaster remains our unfortunate best hope. If we get to a point where ambulatory surgery centers are being used as make-shift ICU beds, we will know that the curve has not flattened, and the country will undoubtedly be in the worse spot. Yet, without that volume, financial disaster looms.

We believe that there is value for healthcare leaders to start now to prepare for COVID + 1.  Eventually, the country will be through this crisis. The organizations that can start to see that now, while not sacrificing the current mandate to provide immediate care, will be better positioned.

Three Priorities for COVID+1

We suggest three priorities for a healthcare leader to prepare for the post-COVID era: Ready the ground for FEMA support, reduce cost, and embrace digital healthcare.

Ready the ground for FEMA support

A detailed review must quickly occur to engage with FEMA preparation and reimbursement for all health systems and hospitals. Even though it is hard to see through the midst of a crisis, this declaration of a disaster is meaningful, and organizations which file first will be better prepared in the future.  Losses — including revenue, labor cost, housing, and increased materials — need to be tracked and accounted for the upcoming FEMA benefits. The time will come when all healthcare organizations understand this benefit; those who accessed the system first will be advantaged.

Reduce costs 

For nearly a decade, industry alarms have been sounding about the inability of hospitals and health systems to decrease expenses[ii]. While revenues have been dropping faster than costs throughout the industry, many health systems have been able to insulate themselves with non-operating income from investments. With regular double-digit returns, that supplement has been life-sustaining for many organizations.

However, with the crash of the stock market, it is no longer realistic to think that health systems will be able to supplement their financial success with gains in their business portfolio. Instead, the success in the future will be far more closely related to the fiscal discipline of the health system rather than depending on endowments.

Of course, we need to ensure that the lower costs continue to maintain high-quality healthcare.  Fortunately, there are many examples of organizations that have been able to reduce costs and provide world-class healthcare simultaneously.  Those organizations which have been avoiding those hard choices while relying on their endowments will be forced to solve that problem — starting with COVID +1.

Embrace digital healthcare 

For more than a decade, the industry has been working to improve telemedicine to a level where payers were willing to pay, and patients felt comfortable receiving care.  With increasing acceptance of industry disruptors in “digital front door” technology, whatever hesitancy there was toward utilization of digital care has been removed in the past 14 days.

No longer will payers or government agencies express the hesitation to endorse this service, and organizations that are better prepared to implement this digital front door for their healthcare organizations on COVID +1 will be incrementally advantaged over other health systems. As an industry, we have been waiting for the digital healthcare transition — over the past few weeks, society instantly accepted the inevitability.

Many healthcare organizations are now able to do the basics related to making appointments online or having e-visits for routine care.  But, what has happened over the past two weeks has standardized virtual care, and people who just a few weeks ago would have never thought to have used the technology have now fully embraced the technology.

Patients who just a few weeks ago thought their entrance into the hospital or their local health system was through the Emergency Room, or the hospital front door, have now realized that they can access a health system through the digital front door. Organizations that can be prepared to address this after COVID +1 will grow and prosper.

Looking Forward

With proper preparation we believe that we can flatten the curve and save lives. That is the primary goal of every person in the country.  However, if we are successful with that effort, healthcare leaders should start now to address the next phase, COVID +1. The goal should not simply be to save lives now, but to continue to do so once the crisis passes.

 

Notes

[i] A shorter version of these ideas was published in Modern Healthcare on April 4, 2020. https://www.modernhealthcare.com/opinion-editorial/even-deep-covid-19-crisis-start-planning-now-what-follows

[ii] In August of 2018 Moody’s Investor Service cautioned that “expense growth continues to outpace reveneue growth for US not-for-profit and public hospitals”[ii] and that trend has continued. See Moody’s Investor Services Research Announcement, August 28, 2018 “Moody’s – US NFP & public hospitals’ annual medians show expense growth topping revenues for second year.”

University of Pennsylvania Seminars Explore Business and Other Implications of COVID-19 (4/7)

The University of Pennsylvania Leonard Davis Institute of Health Economics recently hosted its first virtual seminar on recent COVID-19-related developments. Six experts discussed topics including a realistic timeline for the development of a COVID-19 treatment and vaccine, long-term social distancing options, and the plight of small businesses and hourly workers.

The Leonard Davis Institute, to which The Wharton School’s Health Care Management program belongs, serves as a hub of health services research facilitating the interdisciplinary interaction and collaboration of more than 400 Senior and Associate Fellows.

Listen to the seminar

In addition, Penn’s new Center for Research on Coronavirus and Other Emerging Pathogens presented a number of COVID-19 and coronavirus-related topics in an on-line symposium of Friday, April 3.

Listen to the recordings

Stanford Medicine-Engineering Partnership Launches an Interactive Model to Facilitate COVID-19 Response Planning for Hospital and Regional Leaders (4/1)

Johannes O. Ferstad, BA1, Angela Gu, BS2, Raymond Y. Lee, BA1, Isha Thapa, BA1,
Kevin Schulman, MD3,4, David Scheinker, PhD1,3,4,5 and Andrew Y. Shin, MD6

1Department of Management Science and Engineering, Stanford University School of Engineering

2Department of Computer Science, Stanford University School of Engineering

3Department of Medicine, Stanford University School of Medicine

4Clinical Excellence Research Center, Stanford University School of Medicine

5Department of Medicine, Stanford University School of Medicine

6Department of Pediatrics, Stanford University School of Medicine

Abstract

Contact: Andrew Y. Shin, MD drewshin@stanford.edu

What is the message? Interactive online tools can help local hospital and public health officials understand and plan for the number of people in their area that are likely to require hospitalization for COVID-19.

What is the evidence? Publicly available data, including the most recent data on COVID-19 hospitalization rates by demographics, used to project local hospitalization numbers in an online tool. Link to model: https://surf.stanford.edu/covid-19/

Timeline: Submitted March 30, 2020; accepted after revisions April 1, 2020

Cite as: Johannes O. Ferstad, Angela Gu, Raymond Y. Lee, Isha Thapa, Kevin Schulman, David Scheinker, and Andrew Y. Shin, 2020. Stanford Medicine-Engineering partnership launches an interactive model to facilitate COVID-19 response planning for hospital and regional leaders. Health Management, Policy and Innovation (HMPI.org), volume 5, Issue 1, special issue on COVID-19, March 2020.

The Need for Projections in Planning

Hospitalizations related to COVID-19 could exceed hospital capacity in many areas of the United States without appropriate local preparations.  One of the greatest obstacles to implementing local policies to handle such a surge of COVID-19 hospitalizations is that local leaders have to plan for exponential growth of a highly transmissible pathogen with a 3- to 14-day lag between infection and hospitalization. A simple model that captures these dynamics and projects hospital bed demand a few weeks ahead helps local leaders meet this challenge.

To prepare adequately, local officials need to know how many people in their area will likely need to be hospitalized for COVID-19 and how this compares to the supply of intensive care and acute care beds. Most people infected with COVID-19 are asymptomatic and the proportion of infections that require hospitalization differs substantially between age groups. [1] Moreover, U.S. counties vary significantly in their population age, as well as in their available hospital resources. [3, 4] Projecting the local need for hospital beds requires understanding these risk factors and accounting for the susceptibility of the local population. [2]

Early projections of the potential impact of COVID-19 on local hospitals have forced governmental action; however, the policies implemented across states and counties vary widely. [1, 5] Such differences lead to important variation in disease propagation across counties.  Understanding this variation at a regional level is important to coordinate planning related to the employment of public health policies and the utilization of limited healthcare resources.

The Projection Model

Sources of Data

To facilitate local planning, we built a simple model to estimate the proportion of people in each US county that would need hospitalization given a symptomatic COVID-19 infection. We used the age distribution of the county per the U.S. Census and conditional infection severity rates from the Imperial College COVID-19 Response Team. [2, 6, 7] The model compares the estimated number of individuals requiring hospitalization in the next several weeks to the publicly known numbers of intensive and acute care beds in the region, including length of stay data [8, 9].

Availability and Example Output

To enable use by hospital and public health officials, the model is deployed online as an interactive tool that quickly generates estimates of the number and rate of severe, critical, and mortality case rates for one county or a set of counties. These time series are presented with the number of intensive care and acute care hospital beds available in the corresponding region.

Figures 1 and 2 depict examples of outputs from the model.

 

Figure 1: Screen capture of model (https://surf.stanford.edu/covid-19/, accessed on March 29, 2020) with permission of authors.  Example output showing the model output simulating an intervention that changes the growth rate of COVID-19 hospitalizations on April 20. The plot is a hypothetical situation and not a forecast for any county.

 

 

Figure 2: Screen capture of tool (https://surf.stanford.edu/covid-19/, accessed on March 29, 2020) with permission of authors.

Link to model: https://surf.stanford.edu/covid-19/

 

Updates

As local officials gather new data on the spread of COVID-19, the model allows them to adjust the inputs to the model and generate new and better projections. For example, hospital length of stays (and intensive care length of stays) may vary based on the unique population characteristics within a county. Similarly, current disease burden and/or public health measures may be importantly different across counties.

The large uncertainty around the numbers of people infected and its growth rate make it difficult to evaluate projections generated by more complex epidemiological models. The model allows users to tailor basic input parameters such as hospital length of stay and the impact of public health interventions, such as social distancing, to slow the spread of the virus for a specific county or combination of counties.

When researchers publish new epidemiological data, the model is updated by those maintaining it with new conditional hospitalization rates and their associated length of stays. The model errs on the side of simplicity and transparency in order to better communicate the underlying calculations and uncertainty to non-specialist policy makers.

Estimating Disease Propagation

An important secondary feature of the model is the ability to estimate disease propagation based on the doubling time of hospitalizations, complementing and contrasting the doubling time of confirmed cases.  As the rate of confirmed cases in the U.S. is likely to significantly shift with adjustments in testing criteria and testing capabilities, a hospitalization-based model offers advantages to estimate hospitalization needs in the context of a fluctuating landscape of symptomatic and asymptomatic cases.  As new epidemiological data become available, the model is updated by those maintaining it with new age-specific rates of disease, disease severity and hospitalization along with hospital length of stay.

Looking Forward

Given current constraints on hospital resources, it is imperative to achieve collaborative operational planning and research across the public and private sectors. While hospitals may emphasize the impact of COVID-19 at their individual facility, our model estimates the impact at the regional level. Understanding the regional impact facilitates coordination of planning between public health and hospital leaders facing an extraordinary challenge.

Improved situational awareness enables regional and state leaders to be prepared to tackle the considerable variation in disease penetration and impact across counties. These conversations are facilitated by the ability to study several counties in a region and to vitally understand the sum of the parts that make up the whole.

 

Acknowledgments

We thank Systems Utilization Research for Stanford Medicine (https://surf.stanford.edu/) and the Clinical Excellence Research Center (http://med.stanford.edu/cerc.html) for their invaluable contributions. 

 

References

[1] Li, R., Pei, S., Chen, B., Song, Y., Zhang, T., Yang, W., & Shaman, J. (2020). Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science.

[2] Imperial College COVID-19 Response Team. (2020, March 13). Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. Retrieved from https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf

[3] American Hospital Association. (2018). AHA Annual Survey. 2018. Pennsylvania, PA: Wharton Research Data Services.

[4] U.S. Census Bureau. (2019). American Community Survey 5-Year Data 2018 [Data file]. Retrieved from https://www.census.gov/data/developers/data-sets/acs-5year/2018.html

[5] The New York Times. (2020, March 16). White House Takes New Line After Dire Report on Death Toll. Retrieved from https://www.nytimes.com/2020/03/16/us/coronavirus-fatality-rate-white-house.html

[6] Website: https://surf.stanford.edu/covid-19/, last accessed Mar 29, 2020. [7] Ferstad, J.O., Gu, A, Lee, R.Y., Thapa, I, Shin, A.Y., Salomon, J.A., Glynn, P., Shah, N.H., Milstein, A., Schulman, K., Scheinker, D.  A model to estimate bed demand for COVID-19 related hospitalization.  medRxiv. doi: https://doi.org/10.1101/2020.03.26.20044842.

[8] Yang, X., Yu, Y., Xu, J., Shu, H., Liu, H., Wu, Y., … & Wang, Y. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine.

[9] Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., … & Guan, L. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet.

 

 

 

Fox and Hedgehog Leadership in a Crisis: A Pharmacy Story (Seamless Care Pharmacy, Toronto, 4/1)

Marwah Younis Damani, RPh. PharmD, Managing Director, Seamless Care Pharmacy, Scarborough, Ontario. Medical Director, Community Living Toronto

Abstract

Contact: marwah.younis@seamlesscare.ca

What is the message? Responding to a crisis needs a combination of fox and hedgehog leadership that, with mutual respect, both gathers information and acts quickly.

What is the evidence? Experience in leading change at a specialty pharmacy in Canada during the current COVID-19 pandemic.

Timeline: Submitted March 30, 2020; accepted after revision April 1, 2020

Cite as: Marwah Younis Damani, 2020. Fox and Hedgehog Leadership in a Crisis: A Pharmacy Story. Health Management, Policy and Innovation (HMPI.org), volume 5, Issue 1, special issue on COVID-19, April 2020.

Getting from Sharing Space to Social Distance

By March 2, 2020, Canadians were well aware of the escalating impacts of a novel virus around the world. Yet, while COVID-19 was receiving a lot of air time and the newscasters were calling for stricter measures around infection control, I was at a large pharmacy industry conference at a hotel airport in Toronto, where attendees were sharing laughs and personal space, oblivious to the realities that were already threatening the community.

As a leader of a specialized community pharmacy in Ontario, I realized early that we were in a time of history where we will be affected by something big, yet it did not become clear how big until weeks later. Despite the lack of initial guidance from our industry and our government on how to best move forward, I felt it was imperative to redefine our go-forward strategy given the environment we find ourselves in and the urgency of the situation.

Normally, our pharmacy emphasizes extensive direct contact with clients as part of our services, both in our facilities and theirs. By contrast, the goals of our revised strategy are to maximize staff protection by creating a drive-thru model and minimizing client contact, while updating the operational model as we adapt the business. While this may seem like a small change, the revision was wrenching for our clients and for our staff.

The key question in redefining and executing the new strategy was what style of leaders we needed to act effectively. Nate Silver’s book, The Signal and the Noise [1], draws on an idea by the Greek poet Archilochus that “a fox knows many things, but a hedgehog one important thing”, to describe two types of leaders. Fox-type leaders gather a lot of information, while hedgehogs tend to focus on a few points of information. In many cases, foxes are most effective, because they assess many options. When you need to move quickly, however, we need hedgehogs, preferably in combination with foxes.

Foxes, Hedgehogs, and Dual Leadership

The fox: If you need to be right before you move, you will never win

Foxes need to know all the details and they need to be sure of their next move before they make the move. This delay in action can jeopardize the greater goal in a crisis. In responding to the COVID-19 pandemic, the details were important, but time was of the essence. If we had relied only on fox leadership, we would still be waiting for action.

The hedgehog: React quickly, stop chains of transmission

In times of crisis, you need leadership that is laser focused on one goal, decisive, and action oriented. A hedgehog leader filters out the noise and makes hard decisions quickly. The hedgehog leader doesn’t think too much about all the details of how we’re going to do it, just that we need to do it and we need to do it now.

We needed both foxes and hedgehog leadership

Yet relying only on hedgehog leadership creates a risk of quickly going down the wrong path. In our pharmacy, we needed engagement by both types of leaders. Foxes gathered as much pertinent information as possible and presented the information. The hedgehog then made the calls and created urgency around the change.

Quite simply, both types of personalities were crucial. Without careful attention by the foxes, useful information would not be communicated, and the plan would not have been executed effectively. But without a hedgehog, this process would have inevitably taken weeks, not days, and would have rendered it too little, too late. Our team took on the dual fox and hedgehog challenge.

How Our Pharmacy Moved Quickly While Finding a Fox and Hedgehog Balance

The goal of my specialty pharmacy was to rise from this international disaster as a leader in the sector and to survive with minimal damages. “Be fast, have no regrets, be the first mover”. We heard about the “drive-thru” pharmacy model from different regions of the U.S. and we were warned about pharmacy closures due to lack of staffing. While there was no initial guidance from our college on what to do next, we decided to follow what the world was doing and start reducing direct contact of staff in the pharmacies with patients, who had the risk of being infected and, in turn, infecting our staff.

Data gatherers and providers

It’s important to engage with the stakeholders who will be implementing your decisions for change. We presented our ideas and the information we gathered to our staff. They brought to our attention relevant barriers and challenges that we did not consider before and we worked through those challenges as a team.

Some ideas we decided would not be accommodated. Staff were advocating to allow clients who walked rather than drove to the pharmacy to wait inside the building. We decided that they would still have to wait outside. The hedgehog leader stressed that, while flexibility is usually the key to a successful business, in a crisis situation, strict adherence to the rules was necessary to protect all parties involved.  The foxes were then instrumental in communicating the message about the importance of the rules to get understanding and support from our staff, clients, and the community at large.

Decision makers

Sometimes we simply could not come to a consensus. When that happened, the hedgehog stepped in and redirected people to focus on the bigger goal and made the hard decisions. Some choices met resistance because they risked affecting the pharmacy’s immediate financial top and bottom line, but would ensure that we meet the main outcome.

Hence, in addition to information from the foxes, decisiveness by the hedgehog was critical. In this time of crisis, many stakeholders need more direction than usual as fear and uncertainty renders many paralyzed in the face of decisions. While empowerment and collaboration are the basis of the leadership in our pharmacy team, in this crisis, strong direction was key to mitigating the risks imposed by time.  Indeed, we over indexed on the presence of the management team for the first week to ensure effective implementation of the strategy.

It was a call to arms. We are healthcare practitioners and we are essential frontline workers. We met with the pharmacists, pharmacy assistants, and drivers to share our vision and strategy. Their fox-type insights were invaluable, but their hesitation was ever present, along with fear, anger, and stress. In those moments it was important to rally the troops towards our singular goal, our calling to be a leader in protecting the community. It was clear that we had to start by protecting ourselves if we wanted to achieve that outcome.

Mutual respect

In acting quickly and thoughtfully, we respected both types of leadership. The hedgehog commended the stakeholders for their bravery, acknowledging the sacrifices they were making. The foxes kept the hedgehog informed and addressed the stakeholders’ concerns, which provided them with a sense of comfort.

When there was a lack of consensus or when the information or direction was challenged, the foxes were unsure of how to move forward. The hedgehog, on the other hand, was committed to the goal, focused on alignments and misalignments, ready to make the hard decisions. This sometimes meant sacrificing short term individual comforts for the greater good. With the mutual respect, though, the foxes understood the need to act.

Skin in The Game Creates Wins

A hedgehog must be aware of the inevitable risks. Since this is a crisis, initial losses are likely. One must be willing to show how short-term losses may be worth the long-term gains. Some clients were rightfully upset, and some may go to a different pharmacy. The fear in our team was that revenue will be lost in the efforts to conserve our manpower.

But our decisiveness is a win for both the community and our business. We are showcasing to the community that we are leaders in action and in protecting them. We sent out communications that we can supply any patient’s medications from any pharmacy that is unable to deliver or keep their doors open. Patients who are concerned about the handling costs of a new 30-day limit for dispensed chronic medications were reassured that even if the government does not waive future copays, we will.

In turn, this has allowed us to increase our catchment area for deliveries, which will provide us with more customers and a wider reach. As of late March, we had experienced a record increase in our prescription sales. This has been challenging to implement as, initially, our broader base of deliveries was not fully organized and required multiple trips a day. Nonetheless, we have been able to refine our procedures to make the growth more scalable.

What have we taken away from the story so far? By combining fox and hedgehog leadership, we are reacting to the crisis, protecting our clients, staff, and community, while sustaining our business.

 

References

[1] Nate Silver, 2012. The Signal and the Noise: Why So Many Predictions Fail – but Some Don’t. Penguin.

 

 

 

 

 

 

Why Are We Emulating Italy’s Social Isolation Instead of South Korea’s Targeted Approach? (University of Toronto, 3/30)

Dmitry Krass, Sydney Cooper Professor of Business Technology, Professor of Operations Management and Analytics, Rotman School of Management, University of Toronto

Abstract

Contact: krass@rotman.utoronto.ca

What is the message? This article contributes to the debate on what forms of social distancing policies will be most effective in addressing the health and economic impacts of the coronavirus pandemic. Strict social distancing measures, such as those being used in Italy, elsewhere in Europe, and North America, may lead to unfortunate trade-offs in health and economic well-being, with excessive economic stresses leading the even larger damages to health. By contrast, milder social distancing policies, if combined with strong policies of testing, quarantine, adopting face masks, protecting high-risk groups, safety in public places, and economic recovery, may be more effective in supporting both health and economic welfare.

What is the evidence? Basic cost-benefit analyses, using assumptions based on the recent trends of the coronavirus pandemic.

Timeline: Submitted: March 26, 2020; accepted after revisions: March 29, 2020

Cite as: Dmitry Krass, 2020. Why are We Emulating Italy Instead of South Korea? Health Management, Policy, and Innovation (HMPI.org), volume 5, Issue 1, special issue on COVID-19, March 2020.

High-Risk Response

The response by most governments and public health authorities in the West to the coronavirus pandemic has been guided by the gospel of “social distancing”: essentially freeze all social interactions to “stop the virus in its tracks”. Whole industries (airline, tourism, food service, non-food retail), as well as most educational institutions (schools, universities) have been shut down indefinitely, until evidence that growth curve has been “flattened” is at hand.

One should distinguish between different types of social distancing measures; for lack of better term I will refer to them as “mild” and “strict”. Mild measures are largely voluntary for the general population, while including far stricter policies for known and suspected infection carriers, as well as high-risk individuals. They also include low-cost transmission reduction measures such as wide adoption of face masks, surface cleaning, disposable gloves, as well as cancellation of large-scale events where close personal contact is likely. The vast majority of economic activity is allowed to continue functioning under this model.

Strict measures are very different. They include major infringement of the most basic individual rights (freedom of movement, freedom of assembly, freedom to earn a living) applied to all of the country’s population[1]. The goal is to stop most social interaction, with the accompanying shutdown of large portion of the economy. This has become the new norm of response to the COVID-19 pandemic in North America and Western Europe.

Multiple Aspects of the Social Distancing Responses are Striking

The policies are largely untested. While there is some empirical evidence in the literature indicating that social distancing measures can reduce the number of cases and/or delay the occurrence of the peak of infections (“flattening the curve”), nothing even approaching the scale of economic shutdowns seen today in US, Canada, and most West European countries has been tried before.

The closest case is China’s actions in shutting down the city of Wuhan and imposing various restrictions in Hubei province during January-March, but even these pale in comparison: only one region of the country was affected by the most severe restrictions, and much of the economic activity continued in the rest of the country. The documented instances of social distancing in the literature (dating back to 1918 and 1950’s) were far more limited in scope, including only school closures and event cancellations. Nothing approaching nationwide shutdowns of major industries, wide-scale travel restrictions or stay-in-shelter orders have been tried. The fact that large-scale social distancing is unprecedented flies in the face of the narrative one hears from the media, where such policies are presented as the only reasonable approach, based on scientific truths and accepted practice.

The truth is closer to something like this: We have an idea for a medicine that works well[2] in our theoretical models, and something similar to this medicine saw limited usage some time ago; let us now make it absolutely mandatory for everyone to take. In any other context, this would be irresponsible – so how is it responsible to roll out “shelter in place” and “no non-essential businesses operating’’ policies, that have never been tested before, both with respect to their benefits or harm, across the Western nations?

One is struck by the dichotomy: on the one hand we have several promising vaccines for COVID-19; the early results are promising and human trials have started, but, of course, the vaccine cannot be approved by the FDA until large-scale trials are completed: after all, it may be administered to millions of people and it would be irresponsible to approve it before possibly dangerous side effects are known. On the other hand, when it comes to untested ever-escalating draconian measures with open-ended economic consequences, no such prudence prevails: it is regarded as irresponsible not to implement them.

It appears that costs massively outweigh the benefits – likely by orders of magnitude. To the best of my knowledge, no attempt at cost-benefit analysis – which should be the starting point of any large-scale economic intervention – has been done. The positive impact of the social distancing measures is very uncertain. As pointed out by Prof. John Ioannidis, a prominent epidemiologist from Stanford,[3] we do not have nearly enough data to estimate the potential benefits.

On the other hand, the scale of the economic damage they are wreaking is open-ended: estimates range from 10% reduction[4] in GDP to possible shutdown of whole industries; an airline that is not flying or a hotel that is not operating are hard to keep afloat, even with government help. Note that the 2008 financial crisis resulted in 3% GDP loss, but did not involve the shutdown of whole swaths of the economy.

Many people have already lost their jobs – and we are just days into the strictest measures in North America. Massive additional job losses are expected. The sectors of the economy hardest hit (food service, retail and tourism) also employ disproportionate number of lower-income workers; even a short-term interruption in income is likely to push many people below the poverty line. And all ills of poverty, including serious diseases and shorter lifespans, are sure to follow.

Thus, even ignoring the financial aspect and focusing purely on life-years saved, there is a clear trade-off between the benefits of “social distancing” measures and the economic devastation they will cause. One should add to the health costs the increasing mental stress and anxiety social isolation will cause, with lower-income earners living in cramped accommodations hit hardest. These effects should not be dismissed – solitary confinement in prisons is regarded as a harsh form of punishment, reserved for worst offenders; we are inflicting this on the whole society.

Will the benefits outweigh the costs? The answer is likely “no”: as pointed out by Ioannidis, the current best estimates of the infection fatality rate[5] are very uncertain, ranging from those not much higher than for seasonal flu, to those five times that amount. Surely, when one is inflicting a massive economic burden on millions of people, is such analysis in order?

Yet, not only has no such evaluation appear to have been performed, even suggesting it seems to be regarded as callous and unpatriotic. In a rejoinder entitled “We know enough now to act decisively against COVID-19. Social distancing is a good place to start”[6] to Ioannidis, Prof M. Lipsitch, a no less eminent epidemiologist from Harvard, does not dispute any uncertainties, but merely states that the current course of action is the only choice. One cannot help but wonder if shutting down the economy is a “good place to start”, what is the intended finish?

Even very rough financial estimates show that the current measures are massively ineffective – by orders of magnitude. Take Italy as an example. Between February 24 and March 8, in a series of rapidly escalating steps, some of the most stringent social distancing measures ever were adopted. The whole country was placed under strict travel quarantine; all schools, universities, public venues, and most stores were closed; police began patrolling railway stations and threatening to arrest anyone attempting to travel without a permit, etc. Sadly, these measures are no longer unique: since March 8 many countries have followed suit, and the measures that seemed straight out of some horror movie at the time now look quite commonplace.

As of this writing (March 25), Italy has recorded just over 7,500 COVID-19 deaths, with the number of new cases and the number of deaths appear to have peaked around March 20. The median age of death is around 80 years old. Let’s assume there will be further 7,500 deaths, for a total of 15,000 (an incredible number – this would be 250 deaths per 1M population, vs 2 in China, 2 in South Korea and 0.5 in Japan – all of which appear to be at the tail end of the epidemic).

Let’s generously assume that without strict social distancing measures the number of deaths would be double – a very optimistic assumption as there is little actual evidence that the disease trajectory or the death rate was substantially reduced at all since these measures came into effect. Note that we are not comparing strict social distancing with the “do nothing” scenario – no responsible government would contemplate the latter. Rather, we should be measuring the marginal effect of the economically costly strict social distancing measures vs their “mild” counterparts, described in more detail below).

Using the standard actuarial tables, someone who survived to age 80 has a remaining life expectancy of around 8.5 (males) – 9.5 (females) years. To keep math simple, I will round it up to a 10 (another generous assumption, as most of those dying also have other underlying health conditions). While it seems callous to value a life, policymakers have to do it all the time; a common range of $7-$9M appears to be (e.g., US Environmental Protection Agency uses $8M). With the average lifespan of 90 years (again, rounded up), this works out to $100K per life-year (a likely overestimate). Thus, strict social distancing may have saved a maximum of 10*$100K*15,000 = $15B.

Now let’s look at the cost side. Italy’s per capita GDP in 2019 was $33,156 and the population of 60.5M. Assuming 10% GDP loss[7], this works out to $2,008B – a figure roughly 135 times higher than savings. Put it another way, social distancing would have to prevent over 2M deaths to make costs roughly match the benefits. Applying the same simple calculations to other countries – US, Canada, etc., – leads to numbers that are even more outlandish. The costs exceed the benefits by astronomical amounts[8].

One can of course dispute some of the assumptions above, but when the differences are this large, precision is not the point: for example, even if the GDP loss is only 1% (a figure suggesting that shutting down the economy for weeks is equivalent to a mild economic downturn; e.g., Italy saw a 2.8% GDP loss in 2012 and 5.5% in 2009), the benefits are still 13.5 times lower than the costs.

We are told that the reason we need to “stop the virus in its tracks” by implementing the draconian measures is to ease the burden on our strained medical system – already operating near capacity, it will break under the flood of new cases. But what about our strained economies? The current measures may well have catastrophic effects. One must remember that it is countries with strong economies that can afford strong medical systems, not the other way around. The current policies seem akin to advising someone whose house is on fire to jump into a swimming pool and hold their breath until the fire abates – a 100% effective approach to escaping the fire danger, but hardly a practical survival strategy.

Any time the costs and benefits are several orders of magnitude apart, the policy can only be classified as unsustainable. One should look for alternatives – something, perhaps, less “effective” but also less costly. Continuing with the house fire analogy, perhaps you can jump into the swimming pool and tread water; sure, this is less effective in terms of preventing fire risks – you may still be hit by flying cinders or inhale some smoke, but you will also not replace the burn risk with the certainty of drowning.

The policies are untargeted. The current measures apply to everyone within each region, with some relatively minor differences in severity from region to region. This is only warranted if (1) you do not know who is likely to be transmitting the virus, and (2) you do not know who is at high risk should they get infected. Presumably, if you could identify the likely carriers of the disease, you could isolate just them. And if you knew who was likely to be at the highest risk, you could set up a protective system around just them. The rest of the population could go on with, more or less, their regular lives (subject to mild mitigation measures, such as wearing a face mask, described earlier).

In 1918, when (much more limited) social distancing measures were first tried, both (1) and (2) were true, so universal application of policy was understandable. But this was over a century ago! Neither (1) nor (2) are true today: we do know quite a bit about both carriers and risk groups:

  • We have tests to identify infected individuals. Massive testing, that was implemented in South Korea and that is now being rolled out in North America can identify infected individuals early (during the so-called pre-symptomatic stage).
  • We know the mode of transmission: the infection spreads by droplets (produced while talking or coughing) and fomites (infected surfaces).
  • We also know who is in the inflated risk group: those over 65 and/or people with prior serious health conditions.

However, none of this knowledge is reflected in the current policy: my 83-year old mother-in-law is under exactly the same restrictions as me and my wife who are in our mid-50s, and my 20- to 25-year-old students. Recently, my friend’s daughter tested positive for COVID-19 after exhibiting mild symptoms. Public health authorities directed her and her contacts to self-isolate for 14 days. This is only slightly different than the advice given to the rest of the population in Toronto. In fact, had she lived in many US states, where the population is already under the “stay-in-shelter” orders, there would have been no difference at all.

Limited testing capacity was a huge constraint in the early weeks of the disease spread in North America. With great effort, and at great cost, this capacity has been rapidly expanded – still short of where it needs to be, but far better than a few weeks ago. But if knowing who is and who is not infected has no sizable impact on policy, this effort was largely wasted.

The rejoinder one hears against targeted approaches is the uncertainty: we still have very limited data and many unknowns remain. Does transmission happen only via droplets, or is aerosol (droplets suspended in the air) infection possible? How safe are younger age groups without pre-existing conditions? Somehow, the more serious uncertainties regarding the economic consequences of the current policies are dismissed.

Our focus should not be on 100% certainty or 100% effectiveness; we should instead be looking for policies that are reasonably effective and come at reasonable costs. If implementing various mitigation strategies, isolating the likely carriers, and protecting the likely high-risk groups achieves 80% (say) of the effect of the current policies at the costs of billions rather than trillions, the cost-benefit calculations may become more in line. It is well-known in management science that costs may increase astronomically as one tries to come closer to 100% reliability in a system with inherent uncertainty.

Simple low-cost solutions are eschewed in favor of massively expensive ones. If one looks, side by side, at two recent photos of a busy downtown street (back when our downtown streets were still busy), one from any major Western city (e.g., Toronto or London) and one from any major Asian city, what is the first difference that jumps to mind? I am sure it is the face masks (“surgical masks”): on the Asian photo everyone is wearing them, while on the Western one almost nobody is. In fact, in many places in Asia, appearing in public without a face mask, is regarded as a violation of social norms: callously putting people around you at risk.

In the West, particularly in North America, there has been a tremendous, and very effective[9], public campaign against wearing facemasks as the number of cases of coronavirus initially started to spread – we were told by a variety of public health authorities (including the CDC), and in countless interviews on TV, that face masks are not effective for preventing the illness, that they can even be dangerous, they should be avoided, etc. Instead, we were told[10] to cough or sneeze into an elbow (presumably having a sleeve full of droplets that may rub off on surfaces is quite safe).

This advice flies in the face of common sense, scientific knowledge[11], and the experience of anyone showing up with a cough to emergency room or COVID-19 testing center: the first thing you are handed is a face mask; this is before any testing takes place. The logic is clear – if you are infected, you are a danger to others, and a face mask cuts the risk of you infecting others via droplet production by 80% or more (the protection it imparts to you from being infected by others is much lower, but still quite significant – perhaps reducing your own risk by 20%). Thus, if you are a potential danger to others after crossing the threshold of the testing center, were you not just as dangerous before? Or after?

Why am I focusing so much on a humble face mask? Because this is a perfect example of a simple, low-cost solution that, while not perfect, cuts down the probability of infection dramatically. If indeed an 80% reduction in the probability of being infected by a known or probable COVID-19 carrier can be achieved by simply slapping on a face mask, would this not be the first step any responsible public health authority should consider? If instead of focusing on PR campaigns against face masks, efforts were focused on building up stocks and production capacity[12] of this rather low-tech device, perhaps some of the current draconian measures could be avoided?

The only reasonable explanation I can think of for the advice not to wear a face mask was to prevent shortages and save masks for health professionals. If so, this is a rather incredible testimony to the ineffectiveness of the initial response: instead of working with the industry to massively increase the production capacity during January-February of 2020, the decision was made to provide obviously misleading information to the public. The message is being reinforced every day – while Asian public figures are wearing face masks during their press briefings, reinforcing their importance to the general public, North American and Western politicians never wear them during public appearances.

Other natural low-tech solutions abound. Hang packs of tissues next to door handles and elevator buttons in public spaces to minimize surface contact. Urge restaurants to use disposable plastic sheets as table and chair covers. Encourage people (particularly members of high-risk groups) to wear disposable gloves, goggles, etc. Would these be 100% effective? No! But they could significantly cut the chances of transmission/ infection at negligible costs.

Response Model: South Korea or Italy?

There seems to be two prevailing modes of response to COVID-19 pandemic; for ease of reference I will dub them “Italian” model and the “Korean” model.

Italy: The Italian model largely follows the escalating steps of economic shutdown and social distancing described above. It seems to be patterned on the steps taken by China in Hubei province (so perhaps calling it the “Chinese” model is more accurate), but Italy has taken it significantly further, shutting down the whole country, rather than just one region. Most countries in the EU seem to have adopted a version of the Italian model. The US appears to be taking it further still, issuing “shelter in place” orders for ever-increasing number of states, so perhaps we will soon be calling it the “American” model.

South Korea: South Korea, on the other hand, has followed a tightly targeted approach[13], focused on deploying large-scale testing to identify the infected individuals early, preventing them from infecting others through tightly-enforced quarantines, voluntary and inexpensive social distancing measures, and almost universal use of face masks. Schools, universities, eateries, and stores remain open, no significant travel restrictions on the citizens have been imposed (though there are tight controls on the incoming traffic). A similar model has been adopted by Singapore, and Taiwan.

Hybrids: Some countries, e.g., Japan and Sweden have followed a “hybrid” approach. These involve closing some schools, universities, tourist attractions, as well as canceling some events, but keeping businesses largely open.

Comparing the models: So which of the two prevailing models should a country follow? By now, the results are well known; I summarize them on Figures 1 (cumulative daily cases, log scale) and 2 (new daily cases, linear scale) below[14].

 

The yellow line on both Figures is Italy. In spite of the extreme measures described above, the total number of cases is second-highest after China, and the number of new daily cases remain stubbornly high (though, thankfully, leveling off in the last few days). The CFR (case fatality ratio, number of deaths over the number of cases) is 10.9%, the total number of deaths per million is 124, and the medical system is overwhelmed dealing with 3489 critical cases. Most other Western countries (solid lines on Figures) seem to be following roughly the same pattern as Italy.

The dashed blue line (South Korea) behaves markedly differently: the number of cases levelled off just under 10000, the growth rate of the number of cases is near 0, the average daily number of new cases is steady at about 100, CFR is 1.1%, the number of deaths per million is 2, and there are only 59 critical cases. In short, while all the other countries in the chart are still struggling with bringing the epidemic under control, South Korea seems to have done so.

Given this drastic difference in results, the expected take-away would be: let’s avoid the Italian model, and adopt the Korean one as soon as possible. Instead, and quite amazingly, the lesson learned by the policymakers seems to be entirely different: look at what a horrible mess Italy is in, even though they took all these drastic steps; unless we adopt even stronger measures, things will be even worse here. Thus, the Italian experience is used to justify the ever-more draconian measures, while the Korean approach is only mentioned in passing (“they too adopted some social distancing measures”).

Why is the Italian model less effective? The question of why the Italian model of response has been so much less effective than the Korean one is quite interesting and deserves in-depth study (on would expect South Korea to be crawling with public health officials from all over the world trying to find the answers; however, I suspect, this is not the case). Why have strict social distancing measures in Italy largely failed, while far milder ones in South Korea proved successful?

A possible answer lies in the observation in the WHO report that most infections in China happened within families (family attack rate was up to 10%), while community spread was not a key source of new infections. Forcing families to stay together in often cramped accommodations increases the social distance between households, but certainly decreases them within, which may lead to higher infection rate, particularly if new infections are not detected early (there is evidence that the most virus shedding happens during the earliest stages of the disease).

This is, of course, just a hypothesis. One thing is clear; however: expecting Italian-style measures to result in quick wins or “flattening the curve” is not realistic. What is being bought by paying the enormous economic price is not clear.

Take-Aways: Targeted and Sustainable Response

I believe it is imperative that we, in North America, move away from the Italian model, which is, at best, of limited effectiveness and is economically unsustainable. Instead, we should move towards the Korean one as expediently as possible. The overriding principles should be: adopting actions that target the response to the disease and inexpensive measures that limit the transmission of the infection, while avoiding large-scale untargeted ones that damage the economy.

What are the specific steps that should be adopted? The list below is far from complete, but seems like a good start.

  1. Early and massive testing. This is the lynchpin of the Korean model and must be the centerpiece of the North American one. After some initial missteps, great progress has been made in rolling out a network of testing sites. We are not yet where we need to be: testing is still limited.

As mentioned earlier, by the time the fever sets in, the most infectious phase may have passed, so ideally testing should extend to anyone who has developed a dry cough. In addition, in order to minimize the spread of infection, the results of the test must be available quickly – within hours (in South Korea they are often available within minutes). At the moment, depending on the test site, it is more likely to take days[15]. Thus, both the availability of testing and the speed of evaluation must increase. However, testing is only useful if it guides targeted response; if the current policies are continued the main value of testing is lost.

  1. Effective quarantine of positive cases. Self-isolation at home may not be the best model: for those living in shared accommodations there is a very high danger of infecting members of the household (sadly, by the time someone is displaying symptoms and is tested, members of the household are likely already infected). It is not reasonable to expect someone to stay shut-in for 14 days – they must go out to get food, dispose of garbage, etc. In the process, they may infect surfaces (door handles, elevator buttons, etc.). Hotel-style quarantine centers, where infected individuals with mild cases can be safely monitored and isolated may be a better idea. In general, monitoring of individuals who have tested positive must be quite strict – another lynchpin of the Korean model, that employs electronic tracking coupled with stiff penalties to enforce quarantine orders.
  2. Wide adoption of face masks. Until the epidemic is well under control, wearing a face mask should be the norm for everyone. This is an extremely important, and inexpensive tool and should be adopted widely – production capacity must be ratcheted up. Face masks should be available for free at all building receptions, offices, etc. We would be foolish not to use a tool that can drastically reduce the risk of transmission of the disease at minimal cost. Needless to say, this implies that the supply shortages of face masks must be solved.

While during official press conferences one hears about tens of millions of face masks being manufactured and more available in FEMA stocks, the reality is quite different – I just sent some face masks to my daughter – an emergency room doctor in the US – whose hospital (a large and well-known institution) is running short. The stories one hears from medical personnel in Canada are similar.

Face mask shortages, as well as those of other personal protective equipment (PPE), are a badge of shame for North American authorities – with two months to prepare, this basic issue was not resolved. One immediate source of face masks is Asia[16], where supplies appear to be plentiful; perhaps a few planeloads per day cannot be brought in until the North American face mask supply chains are working.

  1. Protect high-risk groups. Seniors homes, rehabilitation centers, social housing catering to elderly population – these are facilities where tough quarantine measures are entirely justified: tightly controlled access, testing all visitors, quick identification and removal of residents displaying symptoms, etc. Prevention of infections in these facilities is crucial to easing the potential burden on the medical system[17]. The same protections must be extended to people with serious pre-existing health conditions (respiratory, etc.).

Some other common-sense measures along these lines:

    1. All elderly and high risk individuals should be identified, advised of the risks they are facing, provided with protective gear (masks, gloves, hand sanitizer), and instructed in its proper use. They should be advised to minimize contacts with others or trips outside their home until the disease abates.
    2. All families with a live-in elderly of high-risk relative should be similarly instructed.
    3. Regular monitoring of elderly and high-risk individuals by telemedicine should be adopted.
  1. Adopt sensible measures to make public places as safe as possible. This is mostly about surface cleaning, minimizing surface contact (tissues, disposable plastic covers, etc.), increasing the frequency of cleaning of public transit, etc. Many of these measures have already been adopted; more could be done.
  2. Get the economy working again! In the face of rising number of cases, this is politically a very hard decision, but a necessary one. The current policy is likely to lead to a disaster. With the industrial heartland of the US under “stay-in-shelter” orders and most businesses shut down, how long before a wave of business bankruptcies and layoffs becomes a tsunami? How long before financial institutions, that never planned for this sudden and complete economic shutdown, develop problems?

How long before law and order begins to break down in the face of increasing desperation? The current measures were originally set through the end of March. They cannot be allowed to last any longer than that.

    1. We have one to two weeks to solve shortages of face masks, PPEs, test kits and test processing capacity. Nothing should have higher priority than that – the Korean model cannot be put into effect without this.
    2. Businesses, including hotels, airlines, food service, etc. must be allowed to reopen.
    3. Day cares, schools, and universities should reopen. There is little one can think of that is more damaging and less useful than closing schools: the children they cater to are not at risk, the parents cannot go to work, etc.
    4. Mild, economically sustainable social distancing measures can remain. Korean-style apps identifying points where infections were detected and advising people to stay away from these areas until cleaning is complete may be useful. Limiting the number of people in stores at one time, limiting the density of people at sporting events (e.g., only 50% of tickets to sporting events can be sold), closing non-essential and hard-to-disinfect venues like museums – all of these may be continued until the new case counts collapse to South Korean or Chinese levels.

What About the Burden on the Medical System?

Of course, one might wonder: what about the elephant in the room – the increasingly stressed medical system? Will the cancelation of strict social distancing measures not increase the burden to an impossible level? I have three responses to that:

  1. Increase medical capacity. Targeted actions to increase the capacity of the medical system are essential. Many of these are under way (the use of hospital ships and military stockpiles), more can and should be done. As long as the economic stability of the country is not threatened, these measures are affordable.
  2. Effective actions will reduce demand. Measures 1-5 described above may achieve as much, or more, to control the number of cases requiring medical interventions as the current “blunt force” approach; this seems to be the lesson from both the Korean and Italian experience. One must remember that the number of newly infected cases detected is not very pertinent to the medical burden: most (80%+, perhaps more if testing is further expanded) of these cases will result in mild or no symptoms, with no required medical treatment beyond basic support during the quarantine. The burden on the medical system will largely be driven by the at-risk population; hence the effective implementation of point 4 is crucial. The introduction of new drugs (already under way, although timing and effectiveness is uncertain) that can reduce the length of stay in the hospital and/or avoid the need for intubation will further reduce the burden.
  3. The alternative may be worse. If the economic breakdown scenario in point 6 is allowed to develop, the medical system will have many more issues to deal with than the COVID-19 epidemic. Already, gun sales in the US are skyrocketing; population is nervous and breakdowns of law and order are increasingly likely. The faster life is allowed to return to some semblance of normality, the better will the society and the medical system be equipped to focus on the COVID-19 pandemic.

Looking Forward

The “no free lunch” maxim in economics remains valid when applied to our response to COVID-19 pandemic. By adopting strict social distancing measures and shutting down much of the economic activity in the process, we are, whether we admit it or not, trading off potential life years saved by, hopefully, bringing the disease under control faster vs. life years lost due to the sharp rise in unemployment, likely increase in poverty, and the various medical and social ills associated with reduced income.  In looking for the right balance between measures that are effective in halting the spread of the infection and are economically sustainable over the long term, we should adopt best practices of countries that were, apparently, able to deal with the pandemic effectively without bringing their economy to a halt. These practices are based on identifying and effectively isolating infected individuals early through massive testing, and adopting low-cost but effective measures like facemasks and other “mild” social distancing measures.

 

Notes

[1] A good example is the current policy in France is to allow only individual exercise – thus members of the household living together are not allowed to go for a walk.

[2] A recent much-quoted paper from the Imperial College London “Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand” https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf is a good case in point. The paper uses a theoretical model that has a great number of parameters, with largely unknown values. The model is “calibrated” to early case trajectory but not the full one. As a result, nearly one-third of the population is projected to be infected eventually (why has this not happened in Wuhan where the total number of cases is less than 1%? Or Japan? Or South Korea?). The dangers of using models with poorly understood data are discussed in detail in the reference in the next footnote.

[3] Ioannidis, J. P.A., “A fiasco in the making? As the coronavirus takes hold, we are making decisions without reliable data”, STAT, March 17. 2020, https://www.statnews.com/2020/03/17/a-fiasco-in-the-making-as-the-coronavirus-pandemic-takes-hold-we-are-making-decisions-without-reliable-data/

[4] A recent guidance from Morgan Stanley projected GDP contraction in the US of 2.4% in Q1 2020, followed by a contraction of 30.1% in Q2, with unemployment rate in Q2 averaging 12.8%.

[5] Not to be confused with the “case fatality rate” – the ratio of deaths to known cases, which is widely reported, but misses the point because testing is heavily skewed towards people displaying serious symptoms.

[6] Lipsitch, M., “We know enough now to act decisively against Covid-19. Social distancing is a good place to start”, STAT, March 18, 2020, https://www.statnews.com/2020/03/18/we-know-enough-now-to-act-decisively-against-covid-19/

[7] This, of course, depends on the length of the shutdown. But if it lasts for months, as many epidemiological models suggest, we may see economic impact on the scale of the Great Depression, i.e., about 25%

[8] A paper “Economic Cost of Flattening the Curve” by Broke-Altenburg and Atherly, March 24, 2020 https://theincidentaleconomist.com/wordpress/economic-cost-of-flattening-the-curve/ reaches similar conclusions, with an important difference – instead of estimating the number of deaths from empirical data as above, the use CDC scenario analysis model that estimates the number of deaths in US between 200,000 and 1.7M, depending on mitigation strategy. These numbers appear totally out of line with the actual number of deaths recorded by China, South Korea, Japan, and other countries where the brunt of the epidemic appears to have passed. Interestingly, even with these hugely inflates number of deaths, the conclusions are similar – the economic case for the current policy is not there.

[9] The fact that face mask stock were depleted retail stores in North America by the end of February, yet one rarely sees them on the street testifies to the effectiveness of the PR campaign – even the ones who bought them were apparently convinced not to use them

[10] This is still the advice e.g. in the public health commercials running in Ontario at this moment

[11] M. Lin, “How to fight the coronavirus SARS-CoV-2 and its disease,COVID-19”, https://drive.google.com/file/d/1ZaiDO87me4puBte-8VytcSRtpQ3PVpkK/view?fbclid=IwAR22G45xuIa0n-Dfx0QHFlC-rJSj-H2ZYV_WACSqua06TGQpzqq9-ERBkzU

[12] It appears that instead of building up stocks, the Canadian authorities were depleting them, shipping 16 tons of personal protective equipment to China in February, 2020 https://www.theglobeandmail.com/politics/article-ottawa-faces-criticism-for-sending-16-tonnes-of-personal-protective/

[13] “South Korea’s coronavirus response is the opposite of China and Italy – and it’s working”, https://www.scmp.com/week-asia/health-environment/article/3075164/south-koreas-coronavirus-response-opposite-china-and

[14]CSSE (JHU) COVID-19 Dataset, retrieved on March 20, 2020. https://github.com/CSSEGISandData/COVID-19/blob/master/csse_covid_19_data/README.md

[15] The author has heard from front-line doctors in both US and Canada of results taking up to 10 days to come back, rendering the test useless for a disease that can progress from initial symptoms to death in that timespan.

[16] Apparently, China restricts exporting of face masks on a large scale, treating them as a strategic supply. This still leaves countries like Taiwan, Japan and South Korea as potential sources to cover short-term needs. Small-scale shipments can be ordered on a variety of sites, e.g., https://www.alibaba.com/trade/search?fsb=y&IndexArea=product_en&CatId=&SearchText=face+masks+medical+3ply+disposable&isPremium=y

[17] For more discussion along these lines see J. Marshall, “This Should Focus Our Attention on the Vulnerable (News From Italy)”, March 13, 2020 https://talkingpointsmemo.com/edblog/this-should-focus-our-attention-on-the-vulnerable-news-from-italy

Message from the Editors: Management Responses to COVID-19

While the clinical story of COVID-19 is evolving in the medical literature, the management side of this crisis lacks a natural home for timely publications. The editorial team of HMPI has recognized this gap and plans to use this journal as a vehicle to help address this unmet need in providing important management information.

In this ongoing special issue of HMPI, we highlight several brief papers written to help medical system leaders address some of their short-term and intermediate challenges of managing the COVID-19 pandemic. We welcome additional submissions on management innovations, successes and failures, and lessons learned from those addressing the crisis and those preparing for the virus.

Please feel free to circulate these papers, and please send us papers of interest or topics for the editorial board to consider. We will add new articles as we accept them.

The Coronavirus Pandemic and the Costa Rican Health System (INCAE Business School, 3/22)

Alvaro Salas, MD, University of Costa Rica, and Andrea M. Prado, PhD, INCAE Business School

Abstract

Contact: Andrea.Prado@incae.edu

What is the message? In Costa Rica, the National Health System includes multiple mechanisms that are coordinating healthcare activities as the country faces the challenges of the COVID-19 pandemic.

What is the evidence? Alvaro Salas has vast experience managing public health emergencies.  He was the President of the Costa Rican Social Security (CCSS) during the Figueres Olsen government 1994-1998.  He is known as one of the founders of the primary healthcare public system in Costa Rica.  Salas was also Director of the Hospital Calderon Guardia, a third level public hospital, and Board member of the (CCSS).  He is currently a Professor of Public Health at the University of Costa Rica.

Timeline: Submitted: March 18, 2020; accepted after revisions: March 19, 2020

Cite as: Alvaro Salas and Andrea M. Prado. 2020. The Coronavirus Pandemic and the Costa Rican Health System. Health Management, Policy and Innovation (HMPI.org), volume 5, Issue 1, special issue on COVID-19, March 2020.

“The day will come when a sneeze in the East will generate a cataclysm in the West,” Libia Herrero, MD, said in a talk about viruses at the University of Costa Rica, some years ago.  This day has arrived!  Against the pandemic, public institutions need effective action to stop transmission and provide necessary treatment.  Prior experience and the ongoing response to COVID-19 in Costa Rica offer important lessons.

Since the 1980s, when Costa Rican authorities established the National Health System, the country has faced multiple epidemics and pandemics with satisfactory results.  What allowed the country to achieve these results? What are the reasons why the cholera epidemic that originated in Peru in the early 1990s with hundreds of thousands of cases and hundreds of deaths, only had 35 cases in Costa Rica—half of which were by people who caught it abroad.  Similar success happened with SARS, H1N1, and others.  In this article, we discuss some of the features that allowed Costa Rica to effectively deal with previous pandemics and are being brought to bear on COVID-19. We hope this experience will provide insights to public authorities in other countries.

Costa Rican Health System

Costa Rica has a National Health System (NHS) through which the government coordinates its efforts to deal with a pandemic. The NHS, which was established by executive order in the mid-1980s, defines roles for different actors in the system.

Institutions

Multiple institutions are important across the scope of the NHS. Each of these actors participate in carrying out and coordinating efforts against a pandemic in Costa Rica.

  • Ministry of Health: The Ministry of Health plays two roles: (1) it provides health services at the first level of care, based on the Primary Health Care strategy; (2) it is the political arm, directly related to the President of the Republic, in the health sector.
  • Costa Rican Social Security System: The Costa Rican Social Security System (CCSS, for its acronym in Spanish) provides general, specialized, and hospital medical services. The CCSS manages the public network of hospitals and clinics throughout the country.
  • University of Costa Rica: The University of Costa Rica oversees the training of human, administrative, and technical resources, including doctors, nurses, microbiologists, dentists, pharmacists, and others.
  • National Institute of Aqueducts and Sewers: The National Institute of Aqueducts and Sewers (ICAA, for its acronym in Spanish) is responsible for supplying water for human consumption and for channeling wastewater.
  • National Insurance Institute: The National Insurance Institute (INS, for its acronym in Spanish) administers professional risk insurance programs.
  • Other ministries: The Ministry of Planning and Economic Policy and the Ministry of the Presidency participate as organs of the national executive.

Four principles

Since its inception, four basic principles of the National Health System have shaped political and technical efforts. The first and most important of these principles is that the Costa Rican state is responsible for the health of all citizens. Second, the Ministry of Health is the guiding institution for health matters. Third, integration and coordination of the multiple institutions that constitute the NHS is imperative. Fourth, promotion and prevention are the foundation of the health system. These principles constitute the legal framework on which the National Health System is based.

Distribution of services and skills

The broad distribution of health facilities around a relatively small country (about 5 million people over 51,000 square kilometers) allows the population to access services without having to travel long distances.  In 1994, when the Health Sector Reform law was approved, the Ministry assumed stewardship for sectoral health, establishing headquarters in each of the cantons and administrative regions around the country.

In turn, the health system provides effective coverage with administrative and medical staff. Technical and professional personnel are part of the staff at the headquarters. Health Ministry personnel include experts in public health, statistics, and epidemiology.

The CCSS has health facilities in each of the country’s 82 cantons and seven health regions, starting with the first level of care.  The CCSS manages 1,113 Basic Teams for Comprehensive Health Care (EBAIS, for its acronym in Spanish) distributed in each community around the country—one facility and team for every 5,000 inhabitants.

The CCSS also provides health services at the second level of attention through 117 Health Areas Headquarters (HAH) located in the main cities of each canton.  These HAH serve as a professional and technical support team for the EBAIS, with general doctors and some specialists, professional nurses, dentists, microbiologists, social workers, psychologists, and pharmacists, to carry out all activities related to prevention, health promotion, healing, and rehabilitation. Each health area manages its operating budget, which gives them great flexibility and autonomy.

Finally, the CCSS offers a third level of attention through 29 general and specialized hospitals for patients referred from the primary level of attention (i.e., EBAIS).  This network of health facilities promotes early detection and eases the navigation of patients through the system.

Support systems

Five key support systems throughout the country facilitate these efforts, including education, the central coordination role of the NHS, the presence of the National Public Health Laboratory, health care financing programs, and a national digital health record. First, the NHS leverages the high education level of the country’s citizens.  Since the inception of the Costa Rica public education system more than one hundred years ago, primary education has been obligatory for both girls and boys, paid for by the State. With a 97% literacy rate, citizens can follow authorities’ instructions. This behavior is supported by the confidence Costa Ricans have in the country’s health institutions.

Second, the fact that a single political-technical institution, the National Health System, coordinates efforts at the highest level helps generate a single message. The NHS makes decisions that become executive orders and allocates financial resources to cover the needs of pandemic care for the attention of all citizens—insured and uninsured, national and foreign—as defined by the legal framework.

A third feature that strengthens the capacity of the system to face pandemics is the National Public Health Laboratory (INCIENSA, for its acronym in Spanish). All laboratory samples for coronavirus, dengue, H1N1, and Chikungunya, among others, are confirmed at INCIENSA, even when the CCSS clinical laboratories also carry out rapid tests to rule out or declare a patient as a carrier of the disease. This fact strengthens the credibility and confidence of the doctors and nurses who are caring for patients at all three levels of attention. Also, the NHS has health surveillance services with many field epidemiologists in each of the leading health areas and regions.

Fourth, the health sector financing scheme is public, which facilitates the channeling of resources in case of an emergency. The central government finances the Ministry of Health and the University, through budget allocation. The CCSS has a tripartite financing system where employers, workers, and the state contribute jointly to the health insurance fund, pension insurance, and administer the non-contributory regime. To help fund the public expenditures, the INS generates revenues by selling professional risk policies to companies to protect their employees.  Also, the ICAA generates revenues through direct payment for water services.

Fifth, Costa Rica has a national digital health record (EDUS, for its acronym in Spanish). EDUS provides a medical record for all citizens that can be accessed from any health facility within the network.

Coronavirus Outbreak in Costa Rica

The first coronavirus case in Costa Rica was detected in March 6, 2020.  The pandemic arrived in Costa Rica through three foreigners: two Americans and one Cuban.  The latter passed the virus to sixteen people at a regional hospital in the public system, Hospital San Rafael de Alajuela, about 20 kilometers north of the country’s capital, San Jose.

The Costa Rican heathcare system reacted quickly. Immediately, the network of health areas and hospitals responded by reorganizing services and redistributing patients—both hospitalized and outpatient—from the affected facility. The goal was to cut the transmission of the virus among hospital personnel, patients, family members, and health personnel.

As a result of these actions, healthy people no longer had to go to the contaminated hospital.  They were able to be cared for in nearby hospitals and health areas to support the hospital in trouble. In this way, they were able to fill their prescriptions and receive laboratory and cabinet examinations in network hospitals.

Testing for COVID-19 happened quickly, with INCIENSA undertaking all the tests.  Epidemiology personnel carried out a sweep of cases in the hospital and among patients attended by a sick doctor. By March 18, 2020, the system ruled out 855 suspected cases and identified 69 positive cases, with one death of an 87-year-old man.  The search for suspicious cases continues. When laboratory results arrive, the health authorities treat them as positives.

Care has been distributed in multiple locations. Two cases were being cared for in Intensive Care Units, and seven in public hospitals. The rest were isolated in their homes, supervised by EBAIS personnel.

Several institutions within the national public health system support the ability to create this continuity of care. The national EDUS digital health system has helped link together the efforts. More broadly, the complementary network of health stewardship services is facilitating service reorganization. Financially, CCSS approved a supplemental budget to send home all sick and suspicious people, the caregivers of patients or suspects, in order to help cut transmission of the virus.

Looking Forward

As of March 18, efforts continued in order to detect patients early and decrease transmission.  Public gatherings are prohibited, schools are closed, working from home is encouraged, and borders are only open to nationals and residents.  The NHS continues to work to ensure that the virus does not have a more significant impact on cases or lives.

Our hope is that the Costa Rican National Health System and its coordination mechanisms are strong enough to—once again—deal effectively with a pandemic.  Many countries around the world lack comparable mechanisms. Indeed, we are starting to see governments, such as in Spain, having to “take over” public, private, military, and civil health facilities in the country to address the COVID-19 pandemic. Our key message is that it is critically important for countries to have coordination mechanisms, such as those in Costa Rica, to bring together fragmented health care activities when we face challenges such as COVID-19.

 

 

COVID-19: A Reflection and Propagation Model for Latin America (INCAE Business School, 3/19)

Sara Benetti, MBA, and Alberto Trejos, PhD, INCAE Business School

Abstract

Contact: sara.benetti@incae.edu

What is the message? COVID-19 is beginning to affect countries in Latin America, which are drawing on global experience to date to determine how to respond. A propagation model of the virus demonstrates that proactive societies will suffer far less than passive, closed, or even prepared societies.

What is the evidence? Healthcare and research experience in multiple Latin American countries, together with propagation model simulation.

Timeline: Submitted: March 17, 2020; accepted after revisions: March 18. 2020

Cite as: Sara Benetti and Alberto Trejos. 2020. COVID-19: A Reflection and Propagation Model for Latin America. Health Management, Policy, and Innovation (HMPI.org), volume 5, Issue 1, special issue on COVID-19, March 2020.

COVID-19 in Latin America

With the World Health Organization’s pandemic declaration due to the impressive rise in the number of infections, deaths, and affected countries, as well as with the manifestations of the economic effects in the stock markets, many people around the world are beginning to rationalize what is going on and to decode the numerous impacts of the coronavirus propagation. During the last few days, we have all been experiencing such abrupt and impetuous changes at a global level.

Our role as academic members must focus on trying to shed some light on the current situation and make our efforts to help people understand the implications of the coronavirus outbreak, contributing to prevent them to fall into the two dangerous extremes of either intemperate panic or superficial minimization – especially in the face of the apparent disbelief about the seriousness of the situation in many Latin American societies, including some decision-makers and even some governments.

This role is especially important in the Latin American context as most of countries in the region are experiencing the first phases of the outbreak. Moreover, Latin America is a particularly complex and vulnerable region, characterized by different levels of maturity in terms of economic diversification and dependence, political legitimacy, as well as readiness and effectiveness of the healthcare systems. There are currently several countries in the world at the apex of their fight against the coronavirus spread that are adopting different strategies and obtaining differing results.

The ultimate question is what to do as a society and as individuals in this convoluted conjuncture? We can learn crucial lessons from the experiences of countries at different stages of the crisis and identify best practices in order to minimize the risk of reaching an unbearable point of collapse of already fragile systems.

Learning from Global Experience

Some countries have been quite successful in confronting this crisis.  Consider for instance the contrast between Coronavirus in Hubei province — where the disease originated, and the government equivocated before finding a workable strategy — and the rest of China.  In Hubei province, 1,190 people per million acquired the disease, there are still 22,000 active cases, and 6.5% of closed cases ended up in death; the equivalent numbers in the rest of China are 10 per million, 1,100 active cases, and 0.9% deceased.  In China, what worked was quarantine and geographical isolation.

The first and most prominent lesson we can learn from China is that, with the adequate measures, the virus is curable, and the spread is manageable.  However, this result requires substantial decisions with harsh implications for social interactions, common daily life, and economic activities.  The execution of proper measures needs strong political legitimacy and commitment.

Approaches in other countries differ. The experience of several European countries, especially Italy, Spain, France and the UK, seems to suggest that these results could be hard to achieve in more secularized and manifold Western democratic systems. The adoption and enforcement of this kind of measures in most Latin American countries remains an open question, given the risk for governments to lose trust and credibility if—for any reason—the decisions do not prove effective enough to limit the spread of the virus and the consequences on the socio-economic system.

Affected Asian countries are also showing to the world the crucial importance of transparency and data accuracy for the management of the coronavirus crisis.  People need understand what is happening, understand the need of drastic measures of contention, and rapidly change their behavior and habits. It seems to be clear at this point that postponing the reaction is the worse option and it is necessary to actively involve the society to reach effective results. Unfortunately, the decisions taken in some European countries during the last weeks are a dramatic example of how fast things can degenerate once the virus begins to spread exponentially.

Another important aspect of the pandemic crisis is the evidence of which types of measures seem to be more effective in controlling the spread. Here some emblematic examples are Singapore and Hong Kong that, regardless their strong links with China, have been able to properly deal with it thanks to a “from micro to macro” approach based on extensive controls (to both symptomatic and asymptomatic people), the identification and isolation of active cases, and the thorough reconstruction of the network of contacts of infected people.  South Korea achieved similar success –after an initial explosive contagion—largely through massive, well-targeted testing.  Other countries in Northern Europe have suffered large numbers of cases but have concentrated on effectiveness of treatment and kept mortality at bay. For instance, at the time of this writing, Italy has 3.5 times as many cases as Germany, but 97 times as many deaths.

Models of Propagation: Benefits of Proactive Preparation

We created a basic attempt to simulate a virus propagation model. The model is neither sophisticated nor excessively precise, but we think it is useful as an early attempt to understand the effects of some popular measures discussed during these days. In doing so, we reproduce the impacts of different measures that governments around the world are adopting to try to diminish the incidence of the transmission.

Consider the following simulated propagation model. We define five open societies of 100,000 individuals each and we define six possible status for individuals. Each individual is exposed to someone else one per period, with 95% of those exposure happening with a compatriot.

  • Healthy
  • Latent (or asymptomatic)
  • Minor infection
  • Serious infection
  • Immune (or recovered

Based on current data, we set the following transitions, assuming that the duration of each period is one day.

  • Probability of contagion (change status from healthy to latent after meeting with an infected individual): 1/6
  • Probability of changing status from latent to infected: 1/5.1
  • Probability of changing status from minor infection to immune: 1/14
  • Probability of changing status from serious infection to immune: 1/30
  • Fatality rate: 0.14

We assign a type to each society, with five types.

  • Origin society: The one with “patient zero”.
  • Passive society: Has certain contacts with other societies (and therefore a certain probability to getting in touch with somebody that carries the virus) and does not take any preventive measures.
  • Closed society: Isolates from the rest and thus the probability of getting in touch with external individuals is very low.
  • Prepared society: Isolates serious cases and prevents them to get in touch with the rest of individuals.
  • Proactive society: Tkes timely actions to minimize the contact between infected individuals (regardless of the seriousness of the infection) and the rest of individuals, meaning that the probability of spreading the virus is lower.

 

Figure 1. Results of the virus propagation model: Infected individuals

Source: Authors’ calculations

 

Figure 2. Results of the virus propagation model: Deaths

Source: Authors’ calculations

 

The results of the simulation exercise highlight the pointlessness of simply limiting one´s strategy to “closing the country,” as the only effect is deferring the wave, with no substantial gains in terms of infected cases and deaths. Adopting preventive measures, such as isolating the most serious cases, seems to give some better results, but the most effective option appears to be the strict proactive approach that implies timely actions even before the number of cases begins to increase. At least some Latin American countries seem to be on the right track on this aspect, adopting early preventive measures to flatten the transmission curve and keep the number of cases that require medical attention under control and in line with the current possibilities of the healthcare systems.

These exercises also remind us of some hard facts.  The more successful case (the “proactive”), precisely because it manages to contain the speed of the problem, also takes longer before it fades away.  And while yes, successful countries have managed to limit the “exponential growth” phase of the contagion to only three weeks and see a fall in active cases (more people getting cured than getting sick) shortly after.  But that does not change the fact that, past those stages, harsh measures will have to remain in place for a long period.  Those measures carry a heavy logistical cost and will make economic performance quite poor for months, perhaps years, until a vaccine or a cure have been developed, or until enough immunity exists in the population.  Preventive measures will still be needed because different countries will enter quick contagion at different points in time, and because some of those countries will not be able to control the problem before it saturates.

Variation Throughout Latin America

Latin American countries will progressively be affected by coronavirus and in the next weeks we will see an increase in its incidence. Nevertheless, the real impacts will be varied and will prevalently depend on the measures adopted during these days by public authorities and individuals’ reactions. The exposure to risk is not the same for the whole region and the strongest effects will come from different sources, such as the decrease of commodity prices for most of countries in the Southern Cone, the proximity and trade dependence with the USA for countries in the Northern hemisphere, the repercussion of the sudden inhibition of the tourism industry, just to mention a few.

We will all have to make decisions in a more volatile economic environment, characterized by negative shocks to both the demand side (contracted consumption) and the supply sides (difficult access to logistic systems, providers, workers, key resources), as well as troubled financial markets that imply huge losses for both firms and individuals. Some sectors will be more affected than others and, so far, it seems that the new, service-based, high-tech economy is more resilient and adaptable to this type of changes. It also seems that there will be a need for a deep redefinition of international cooperation and intergovernmental organizations, whose roles have been weakened during the last years.

Figure 3. Example of stock price movement during the last 3 months: American Airlines

Source: Markets Insider, retrieved on March 17, 2020 (https://markets.businessinsider.com/stocks/aal-stock)

 

Figure 4. Example of stock price movement during the last 3 months: Zoom Technologies

Source: Markets Insider, retrieved on March 17, 2020 (https://markets.businessinsider.com/stocks/zoom-stock)

Looking Forward

In this troublesome context, many questions remain open for Latin America. Will the political response reinforce the populistic tendency, or will we see a return to more open and moderate dialectics? Will countries be able to implement and support the necessary fiscal efforts to counterbalance the complex economic conjecture? Will organizations be able to think and make decisions for the long-term, even when this implies a sacrifice of immediate profitability? Will we see a profound change in how global value chains are managed, with a better and wider diversification of risks across providers and regions? Will this be an occasion to finally understand the great benefits that technological change can bring to many and diverse sectors, making people more flexible and receptive? Will individuals act as a mutually supportive community and will be able, as a society, to learn how to deal with such challenging incidents in the future?

What is for certain is that—like everything in life—this emergency will come to an end.  It is also certain that the “post-coronavirus” world (and Latin America) will look rather different. Hopefully, after the pain and the sorrow, we would have learned valuable lessons for the future, saw better global relations and coordination, understood the importance of preparing in advance for such extreme events, and be ready to go on stronger than ever.

 

 

Integrating Telemedicine Triage and Drive-Through Testing for COVID-19 Rapid Response (Stanford, 3/18)

Samuel C. Thomas, MD, MS, Harris Carmichael, MD, Stacie Vilendrer, MD, MBA, Division of Primary Care and Population Health, Stanford University School of Medicine; Intermountain Healthcare Delivery Institute, Intermountain Healthcare; and Maja Artandi, MD, Division of Primary Care and Population Health, Stanford University School of Medicine

Abstract

Contact: Maja Artandi martandi@stanford.edu

What is the message? In two weeks, Stanford Express Care was able to scale up telemedicine triage for COVID-19 screening and combine the online services with drive-through testing.

What is the evidence? On-the-ground experience with rapid innovation.

Timeline: Submitted: March 16, 2020; accepted after revisions: March 17, 2020

Cite as: Samuel C. Thomas, Harris Carmichael, Stacie Vilendrer, and Maja Artandi. Integrating Telemedicine Triage and Drive-Through Testing for COVID-19 Rapid Response. 2020. Health Management, Policy and Innovation (HMPI.org), volume 5, Issue 1, special issue on COVID-19, April 2020.

The Value of Telemedicine in a Pandemic

The 2019 novel coronavirus pandemic puts healthcare providers in the challenging position of providing high quality care to potentially contagious patients while striving to prevent further exposure to other patients, clinical staff, and the community. Telemedicine, including telephone and video visits, presents a compelling option for reducing the risk of viral exposure during an outbreak while simultaneously addressing the need to increase access for patients without compromising quality of care.

Telemedicine allows health systems to effectively scale the capacity of their providers and provide “forward triage” – the sorting of patients before they arrive at the Emergency Department [1, 2, 3]. One of the major logistical challenges that health systems face in response to the current pandemic is the integration of telemedicine triage with efficient and safe COVID-19 testing and treatment practices [1]. We are using telemedicine tools to address that issue at Stanford Express Care.

Stanford Express Care is positioned within the larger academic health system, Stanford Health Care, in California to offer same day appointments for patients with urgent medical problems that cannot be seen by their primary care providers. Amidst the growing number of COVID-19 positive cases within the local community, the clinic has become the main access point within the Stanford health system for patients with suspected COVID-19 infections that do not require Emergency Department services. The clinic dramatically shifted its operations, moving from predominantly traditional in-person visits to predominantly telemedicine visits, increasing absolute access through increased virtual shifts, and integrating drive-through SARS-CoV-2 PCR testing – and accomplished these changes in under two weeks.

Prior to March 2020, the clinic offered an average of eight video visits a day, which patients scheduled by phone or through an automatic portal. The remaining 120 appointment slots were traditional in-person appointments. The on-line and on-site staffing included one provider performing video visits for a four-hour shift and six providers seeing patients in clinic for a full day. As the number of COVID-19 cases diagnosed outside China grew, clinic staff and providers increasingly recognized the risk that in-person visits for patients with symptoms consistent with COVID-19 posed to their colleagues and patients.

Therefore, in early March, anticipating both increased patient demand and the need to reduce potential SARS-CoV-2 exposure, the clinic increased the number of video visit appointments to more than 150 appointments per day, a 20-fold increase in virtual contacts. This involved increasing the number of providers performing telemedicine from one to six providers and increased hours from 4-hour to 12-hour shifts.

Patients requesting an appointment with symptoms consistent with COVID-19, including fever, cough, shortness of breath, or sore throat, were triaged into a video slot unless there was a concurrent health concern requiring in-person evaluation, such as chest pain. Given that approximately 50% of all Express Care clinic visits in the winter season were for upper respiratory symptoms or fever, shifting these appointments to a virtual platform represented a significant diversion from typical clinic operations.

At the time of this transformation of clinical services, the U.S. Food and Drug Administration gave permission for non-governmental laboratories to test for COVID-19 [4]. Within two days of the FDA announcement, Stanford Health Care testing for SARS-CoV-2 RT PCR went live [5]. By the following week, the clinic had integrated COVID-19 drive-through testing.

This article highlights how integrated telemedicine triage and COVID-19 testing in under two weeks for Stanford Express Care. Three key activities included: (1) prioritizing video visits as first mode of contact; (2) empowering the provider workforce in clinic and at home; (3) coordinating drive-through testing.

Three Steps to Telemedicine Triage and Drive-Through Testing

Prioritizing Telemedicine Visits

Due to the contagious nature of SARS-CoV-2, Stanford Express Care quickly recognized the need to prioritize telemedicine encounters in order to minimize exposure. The initial efforts focused on screening the schedule for any in-patient visits with upper respiratory symptoms or fever and converting these visits to telemedicine encounters. Next, we initiated new scheduling procedures for any patient meeting criteria across all of Stanford ambulatory care to be redirected to Express Care telemedicine encounter.

A key facilitator specific to Stanford Express Care’s implementation of this program was the existing provider familiarity with the telemedicine encounter. Training had taken place at multiple provider meetings within the prior year, and nearly all providers had completed at least one video visit shift.

We did need to overcome some reluctance. During implementation there were concerns raised by providers regarding patient acceptance of virtual encounters and if these visits would be refused. However, demand for the service quickly outpaced available capacity, and our observations have been that the majority of patients approved of the video visits with many expressing gratitude for the proactive measures to ensure their safety.

Another concern was our patients’ capacity to utilize telemedicine. We found that most patients were not familiar with the logistics of telemedicine scheduling or encounters. However, our medical assistants were able to sufficiently familiarize most patients with the technology during the initial phone call for scheduling of the telemedicine visit.

At the same time, the transition to video had an unforeseen benefit. The request for video visits in order to see a medical provider during the COVID-19 outbreak increased patient awareness of disease containment and exposure prevention.

Nonetheless, we still face challenges. For instance, some patients who screened positive for COVID-19 symptoms where inappropriately scheduled to an in-person visit by the call center. This points out the need for additional feedback and training with the new workflow.

Empowering the Provider Workforce

Partnerships with providers in our network were critically important to implement telemedicine triage. Demand for video visits quickly surpassed the resources the clinic could offer. Therefore, additional primary care providers within the health system were recruited. Despite busy schedules, several providers volunteered for additional shifts.  Providers were able to complete video visits in multiple settings: within the clinic, from their own office, or from home with HIPAA-compliant health system laptops. If a provider felt that the patient who was seen on a video visit needed to come to Express Care for a physical exam or additional studies, that provider was responsible for arranging same day follow up.

To maintain provider engagement, we found it necessary to provide close technical support. Critically, the health system’s information technology offices configured several laptops to allow video visits from remote locations such as the provider’s home. Importantly, this expanded capacity for providers to work from remote locations addressed a supply demand mismatch in the clinical capacity of the hospital system by allowing providers that were otherwise unable to continue clinical care, due to self-quarantine and other social distancing initiatives, to continue productive clinical care while working from home. These providers followed strict guidance regarding HIPAA compliance.

We also needed staffing innovations to support the providers. Expanded medical assistant roles played a crucial part in being able to significantly increase the number of video visits, as they handled testing scheduling for both the clinic and from elsewhere within the health system through triage nurses.

Coordination of Drive-Through Testing

Drive-through testing was a key leverage point that took substantial effort and coordination to integrate into the clinic workflow. When the SARS-CoV-2 RT PCR became available through the system’s laboratory, Express Care was the first clinic to offer the test. Since this test was the first in the region, providers were concerned that hundreds of patients would line up in their cars to get tested, causing increased risk of exposure and additional hardship on ill-feeling patients. To prevent this, the clinic created the aforementioned workflow where patients first required a video visit with an Express Care provider who decided if the patient qualified for testing.

The clinic’s drive-through testing site helped liberate resources and staff, while also necessitating changes in the routine staff responsibilities [6, 7]. If a patient met criteria to be tested for COVID-19 at completion of the virtual visit a medical assistant scheduled testing at the drive-through facility. The lead medical assistant coordinated with the patient to schedule the drive-through testing, answered any questions, and labeled the vials for the specimen collection with the patients’ information. Several rapid cycle improvement processes refined our process and reduced drive-through testing times from an initial 15 minutes to 4 minutes in just two days.

The drive-through testing site was staffed with two providers, or one provider and a medical assistant, wearing protective personal equipment (PPE) consisting of a gown, gloves, N95 mask, and face shield. When the patient drove up in their car, they were asked to show a government photo identification. The name on the vial was verified with the name on the identification. One provider performed the nasopharyngeal swab while the second provider, or medical assistant, was responsible for preparation of testing equipment. Importantly, working in teams of two increased efficiency and adherence to PPE protocol while minimizing possible contamination of surfaces.

Beyond Stanford Express Care

While many of the ideas for our model came from our own experience, we also reached out beyond the Stanford health system. Learning from the experience of other health systems has been crucial for quickly adapting to the daily updates and changes. A key source of information has been the guidance documents and protocols provided to the public by University of Washington Medicine [7].

In turn, our drive-through model is spreading beyond Stanford Express Care. To increase the capacity for patients to be able to get tested for COVID-19, the clinic has shared its telemedicine integration of drive-through testing with other clinics within the Stanford health system. Key to the success of this integration across the system was the support of division, department, and health system leadership, as well as the clear communication of goals and protocols across the healthcare system.

Looking Forward

Given the high volume of patient demand and pressing need to identify COVID-19 positive patients while maintaining safety for staff and community, we adopted the triage methods described in this report. This method will need to be continuously adapted based on the changing local prevalence of disease, testing availability, and clinical personnel resources.  We will continue rapid cycle improvements based on the evolving local factors. Others looking to adopt many of these techniques will need to adapt their approach for their local circumstances as well.

While great strides have been made in shifting in-person visits to video-visits for patients with COVID-19 symptoms, other adjustments may be needed. If testing capabilities become more ubiquitous, it may be prudent to reconsider the video visit-first approach and consider a protocol similar to South Korea where drive-through testing occurs in combination with screening by a provider [8]. Screening visits may also be supplanted by an automated symptom checker with providers following up only in severe cases or following a positive test.

Historically, consistent reimbursement for telemedicine has been a challenge, but in light of the declaration of the national emergency, reimbursement of additional funds and resources from the Centers for Medicare and Medicaid Services and some commercial payers will support such endeavors [1, 2].

We believe that our experience offers lessons for other health care providers. Prioritizing telemedicine visits, empowering the provider workforce, along with a willingness to borrow others’ excellent ideas such as drive-through testing may help mitigate the damage from the current pandemic.

Acknowledgments: Steve Asch; Linda Barman; Thanh Khong; Christopher Lentz; Megan Mahoney; Raj Srivastava 

 

References:

[1] Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. NEJM. March 11, 2020; DIO: 10.1056

[2] Lurie N, Carr BG. The role of Telehealth in the medical response to disaster. JAMA Intern Med. 2018;178:745-6

[3] Eric Neil. UW Medicine CIO’s advice: Prepping IT systems for COVID-19. March 2020. https://www.healthcareitnews.com/blog/uw-medicine-cios-advice-prepping-it-systems-covid-19. Accessed March 15, 2020.

[4] US Food & Drug Administration. FAQs on Diagnostic Testing for SARS-CoV-2. March 2020. https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-diagnostic-testing-sars-cov-2. Accessed March 16, 2020.

[5] Deresinki S, Shin D, Pinsky B. COVID-19. Presented at the Stanford Medicine Grand Rounds: March 11, 2020; Stanford, California

[6] Maxwell DN, Perl TM, Cutrell JB. “The Art of War” in an Era of Coronavirus Disease 2019 (COVID-19). Clinical Infectious Disease. March 2020, ciaa229, https://doi.org/10.1093/cid/ciaa229

[7] University of Washington. UW Medicine COVID-19 Resource Site. March 2020. https://covid-19.uwmedicine.org/Pages/default.aspx. Accessed March 14, 2020

[8] Khun A. South Korea’s Drive-Through Testing for Coronavirus is Fast – and Free. March 2020. https://www.npr.org/sections/goatsandsoda/2020/03/13/815441078/south-koreas-drive-through-testing-for-coronavirus-is-fast-and-free. Accessed March 17, 2020

 

How Hospitals and Health Care Systems Can Prepare for the COVID-19 Pandemic (Boston Consulting Group, 3/16)

Sanjay B. Saxena, MD, Senior Partner and Managing Director, Boston Consulting Group (BCG); Josh Hilton, MD, Partner and Managing Director, BCG; Brett Spencer, MD, Partner and Managing Director, BCG; Amika Porwal, Health Care Knowledge Expert, BCG

Abstract

Contact: Sanjay Saxena Saxena.Sanjay@bcg.com

What is the message? Hospitals and other actors in the health system have pathways to ensure supply of labor, supplies, and space, while avoiding being overwhelmed by demand for care.

What is the evidence? BCG’s experience working with health providers in multiple contexts.

Timeline: Submitted: March 14, 2020; accepted after revisions: March 15, 2020

Cite as: Sanjay B. Saxena, Josh Hilton, Brett Spencer, Amika Porwal. 2020. How Hospitals and Health Care Systems Can Prepare for the COVID Pandemic. Health Management, Policy and Innovation (HMPI.org), volume 5, Issue 1, special issue on COVID-19, March 2020.

Preparing for the Pandemic

Healthcare providers are on the front lines of the COVID-19 fight.  The virus is formidable, and the numbers are daunting.  CDC scenarios suggest 2.4 million to 21 million Americans could require hospitalization [1], and based on the experience in China, roughly 5% of them will require critical care [2].  That’s 120,000 to 1 million people, while current US ICU bed capacity (including all types) stands at about 100,000 [3], with 60% to 80% occupancy rates [4].  Even in a moderate scenario, we face a shortage of critical care beds.

Hospitals and healthcare systems face a second challenge, which is just as alarming. They must take care of critically ill patients while keeping their own staff safe and healthy.  This could prove to be an overwhelming combination for some.

Much has been written about the necessity of “bending the curve” so that our national healthcare capacity isn’t overwhelmed by simultaneous peak demand.  But the fact is, dealing with an epidemic of this speed and scale will require solutions both on the supply and demand side of the equation.  Making sure we have the needed capabilities in place is just as critical—if not more so—than reducing the demand for care.  Moreover, managing our way through the COVID-19 crisis will not be an individual effort, but a team undertaking that will require collaboration across systems, regions, and public agencies.

Ensuring Supply

Hospitals and health systems must develop innovative solutions to prepare for the likely constraints in labor, supplies, and space that are on the near-term horizon. It bears remembering with respect to all three that, while we are treating COVID-19, other diseases do not take a holiday. The normal pressures and stresses on hospitals, clinicians, and the healthcare system will continue.

Labor.  To date, much of the supply or capacity discussion has focused on masks, ventilators, and ICU beds, which are critical considerations (see below), but the most critical piece of the equation is the healthcare workforce—not only physicians and nurses, but those in any patient-facing function (technicians, patient registration, and transport, for example), those in critical support functions (such as environmental services), and those with hard-to-replace skills.

Chinese health authorities and the World Health Organization reported in late February that more than 3,300 health workers in China had been infected with COVID-19. There were at least 18 reported deaths of medical workers, including nurses and doctors who died not only because of infection but also from cardiac arrest and other conditions resulting from severe fatigue [5].  In the US regions experiencing the first wave of cases in, including Seattle and the Northern California Bay Area, nurses and physicians already report feeling exhausted.

No one knows how long the epidemic will last. Hospital and healthcare leaders should start to plan now for a prolonged period of unusual demand.  For many institutions, this will involve working with organized labor leaders to ensure that, while everyone is careful to meet health and safety requirements, administrators have flexibility in these uncharted conditions.

Hospitals have several well-known bottleneck services, such as diagnostic care, specialty care, and ICUs, that are scarce assets in normal times and critical in a pandemic situation. These need particular attention to limit risk to staff and special strategies to make sure they stay up and running. Specialty labor should typically be managed differently from generalist staff and reserved for the most critical efforts, since losing these skills will have an outsize effect on the whole care delivery system.

Additionally, the impact of environmental services and ability to clean and put spaces and equipment back into service quickly should receive greater attention. Hospital room turnover is an operational constraint in many systems under normal conditions; the impacts of delays here will be amplified significantly with this pandemic. There is significant opportunity for innovation around the training and deployment of workers to keep sites, spaces, and equipment operational.

Providers should consider taking steps related to modularization, staff flexibility, and staff support.

  • With respect to modularization, hospitals and health systems can configure care teams in a “pod-like” way. Conventional wisdom says that to drive efficiency within the nursing staff by varying staffing and using travel nurses. In a pandemic, this actually increases risk to the whole staff.  Providers should consider instead organizing shifts so that affected “pods” can be temporarily removed from the system without affecting the whole workforce.  The location of COVID and non-COVID pods is a related issue (see below).
  • To increase staff flexibility and ensure efficient patient flow, providers should cross-train patient-facing functions against the possibility of quarantines and school closures that affect significant portions of the workforce making it difficult or impossible for staff to get to the hospital. Affected functions may include patient registration, triage, cafeteria, and environmental services staff.  Take a critical look at outsourced functions and determine which hospital-hired staff can fill in as back-up capacity. If an outsourced function goes down, can the facility continue to function? Develop rapid credentialing capabilities so that x-ray technicians and nurses that work outside the hospital can be called in if necessary.
  • Viruses don’t keep normal hours; hospital and health system staff are going to need support. Consider commissioning non-critical staff to provide childcare for critical patient-care staff. Ensure caregivers are practicing at the top of their license: the highest-level skills should be assigned where they are really needed while caregivers with lower-level skills take care of other patients and provide services within their competence.

The landscape of available testing platforms and the volume of tests available continues to evolve weekly as diagnostic manufacturers, commercial labs, and private labs bring new technologies and approaches online. The turnaround time for each testing approach should be a key consideration for health systems as they plan where and how to deploy what they have access to. Making critical decisions—whether triage or clinical—in the emergency department and ICU will require the fastest tests possible to ensure efficient management of operations and effective management of patient care.

As our colleagues from BCG recently wrote, the supply of masks, gowns, and other personal protective equipment is another major issue. We estimate clinicians caring for COVID-19 patients can easily go through hundreds of masks a month. Medtech industry executives estimate that Asia produces up to 50% of N95 masks, plus raw materials and fabrics for N95 masks manufactured elsewhere, as well as a large majority of isolation gowns. These supply chains are at risk. Several Asian and European countries have placed export controls on “protective apparel,” including masks, gowns, gloves, and drapes. Nonwoven polypropylene fabrics used as inputs to make N95 masks are in short supply [6].

Products used to treat acute viral illness will experience a short-term jump in demand due to COVID-19 admissions. Examples include IV fluids, IV pumps, IV catheters, and respiratory disposables. IVD diagnostic tests for flu, respiratory diseases, and COVID-19 also will see increased demand.  While many pharma and medtech supply chains have been able to largely meet demand to date from existing inventory, providers need to fully understand their supply chains and identify the top products facing potential supply issues, with a perspective on the next few months, taking into account potential more-aggressive infection scenarios [6].

The surge of cases in northern Italy has focused attention on ensuring adequate ventilator supply.  The need is critical given the number of COVID-19 cases that require prolonged mechanical ventilation. Last month, the Center for Health Security at Johns Hopkins estimated the United States has a total of 160,000 ventilators available for patient care, plus at least another 8,900 in the national stockpile [7]. However, unlike hospital beds, there is no definitive count of ventilators in any given region.  In the event of a significant surge in cases, there is currently no easy way for health officials to know the supply that they can mobilize from hospitals in less affected areas or from such sources as freestanding ambulatory surgical centers, transport vents, and pediatric vents.

One potential solution is for systems to work out plans for community pooling of capital equipment resources such as infusion pumps and ventilators to meet shifting demand.  This could involve physically moving equipment to current centers of high demand—from Minneapolis to Seattle, for example—and then back again, or elsewhere, as the spread of the disease warrants.  While there are number of issues surrounding their application in this situation, utilizing home ventilators may also be part of the solution.

Clinicians may also need to consider strategies to negate or delay the need for mechanical ventilation [8]. Case reports from Wuhan suggest that the use of BiPAP or continuous positive airway pressure (CPAP) equipment may delay the need for intubation and reduce ventilator demand [9]. Unlike ventilators which are difficult to procure, home CPAP machines could be readily obtained for hospital use and, if proven clinically effective, they could buy critical time for some patients in the event of acute ventilator shortages. Developing and deploying non-invasive ventilation strategies for COVID-19 should incorporate lessons learned so far from this pandemic as well as treatment effectiveness in prior influenza cases, such as H1N1.

Space. We have to assume that beds in hospitals, ICUs, and isolation wards will soon be at a premium.  This puts a premium on planning.

Physical spaces must operate at the top of their license as well, which means using ICU beds only for the critically ill, and not for isolation, and promptly moving patients who no longer require intensive care to other sites.  Management must think about all spaces in the health system and how they can be best used, including routine clinics, ambulatory care centers, and urgent care facilities.  Underused hotels, which may be available due to lower travel, can present an option for extra capacity, especially for patients with noncritical conditions.

Providers may also want to investigate modularizing physical locations to separate COVID from non-COVID patients and staff. They should begin exploring HVAC strategies for creating more negative pressure wards that keep germs from spreading, as Evergreen Hospital in Kirkland, Washington, which had the country’s first fatal case of COVID-19, has done.

Virtual ICUs, in which intensive care specialists provide care remotely, and modular or mobile clean rooms, which expand critical capacity quickly, could be important parts of the space solution for many providers.

Managing Demand

The implications of an overwhelmed healthcare system, in which resource rationing may become necessary, can impose both operational and ethical dilemmas.  This has already become an issue in Italy and other places.  Providers won’t be able to address demand on their own; they will require support from government leaders and health authorities. They will also need to work with these authorities on containment measures.

Here are some ways in which hospitals and health systems can help manage demand.

Steer New COVID Cases to the Best Diagnostic or Treatment Place.  The first step will be about putting sick people in the right care setting. Patients understandably will be anxious, even panicked, but the experience of other countries shows that many cases are mild or non-life threatening.  Providers should develop strategies for keeping worried but mild-symptomatic people out of hospitals using digital and decentralized triage approaches. For example, Singapore has actively directed patients looking for testing away from primary care sites to designated testing centers, which preserves both precious delivery capacity and scarce infection prevention supplies.

Telemedicine, using both formal and informal consumer video and social media platforms, can help guide patient decision-making in the early stages of illness or when symptoms are mild.  Hospitals should investigate using local clinics and urgent care centers as designated triage sites.  EMS staff can be trained to manage community populations and keep noncritical patients at home, or take them to designated triage facilities, rather than bring them to the hospital.

Use Diagnostic Resources Effectively.  Health systems need guidelines for their lab facilities on what constitutes essential and nonessential priorities. Clinicians and the public both need clear information and communication on where to go for care and when and what and will be tested and when. Communications need to be carefully coordinated between hospitals and health systems and local and regional health authorities.  Rapid deployment of digital tools and telemedicine solutions, temporary relaxation of rules for quicker digital engagement, and upskilling of personnel who can use these tools can all help. Larger systems can work to increase staffing capacity and hours at urgent care centers as a first point of contact for less critical cases.

Actively Manage Non-COVID Needs.  Other diseases will compete for attention, capacity, and resources, even as providers move to deprioritize nonessential care and procedures.   Managements and clinicians will need to make decisions on this balance daily, or even hourly.  Within larger systems, providers can allocate hospital space by moving lower acuity patients out of higher acuity settings.  Across systems, regional bodies can analyze where excess capacity exists and consider grouping patients in facilities by acuity level. They can also investigate activating additional capacity by reopening recently closed hospitals and hotels, as occurred in Kirkland, or by using nearby military bases.

Addressing Other Factors

Many of the supply and demand moves suggested above could push the envelope of current legal and regulatory guardrails.  Governments and policy makers will need to develop guidance on how to think about these in context of doing what’s right for the patient in unprecedented times.  Providers, which have more immediate concerns, should not spend their time second guessing what to do or limiting innovation. The declaration of a national emergency should help, not only by freeing up resources but also by allowing the Secretary of HHS and other federal agencies to bypass certain regulations and provide more flexibility for hospitals and physicians.

There may be ways to extend or improve the efficiency of care through greater community or regional collaboration.  While such initiatives are certainly being contemplated by governments and health departments, individual health systems should also be actively thinking about how to collaborate or partner with others on the front end of this crisis.  Pooling resources is complicated requires management multiple issues set of issues, among them:

  • Access to medical records and systems by nonemployees
  • Sharing nursing pools if nurses are not trained on another hospital’s systems
  • Communication to employees in pooled groups such as via email and phone
  • Sharing ventilators and pumps of different brands, which can require training on how to use them

The allocation of resources in such arrangements can be challenging as well.  Keeping track of how many beds, patients, or nurses are in any given location, and communicating to the front lines about where to send people, depending on the severity of their conditions, becomes a task with dynamics similar to emergency dispatch.

Looking Forward

All that said, the risk mitigation and planning that healthcare providers undertake now will undoubtedly have positive effects on their readiness for this and any future pandemics. The US health system and other stakeholders have the resources they need to respond well. We all must use those resources effectively and in a coordinated manner, both as individuals and as parts of the system.

References

[1] Fink, S. Worst-Case Estimates for U.S. Coronavirus Deaths. The New York Times. 2020 March 13. Available from: https://www.nytimes.com/2020/03/13/us/coronavirus-deaths-estimate.html?referringSource=articleShare

[2] Specht, L. What does the coronavirus mean for the U.S. health care system? Some simple math offers alarming answers. Statnews. 2020 March 10. Available from: https://www.statnews.com/2020/03/10/simple-math-alarming-answers-covid-19/

[3] American Hospital Association [Internet]; c2020 [cited 2020 March 14]. Available from: https://www.aha.org/statistics/fast-facts-us-hospitals

[4] Wunsch, H., Wagner, J., Herlim, M., Chong, D., Kramer, A., Halpern, S. ICU Occupancy and Mechanical Ventilator Use in the United States. Critical Care Medicine [Internet]. 2013 December [cited 2020 March 14]. Available from: https://journals.lww.com/ccmjournal/Abstract/2013/12000/ICU_Occupancy_and_Mechanical_Ventilator_Use_in_the.6.aspx

[5] Su, A. Doctors and nurses fighting coronavirus in China die of both infection and fatigue. The LA Times. 2020 February 25. Available from: https://www.latimes.com/world-nation/story/2020-02-25/doctors-fighting-coronavirus-in-china-die-of-both-infection-and-fatigue

[6] Farber, A., Aylor, B., Rosenberg, B., Danger, T., and Schulze, U. Critical Priorities for Pharma and Medtech in Response to COVID-19. Boston Consulting Group external publication. 2020 March 11. Available from: https://www.bcg.com/publications/2020/coronavirus-critical-priorities-pharma-medtech-response.aspx

[7] Wan, W., Cha, A., Sun, L. This is the coronavirus math that has experts so worried: Running out of ventilators, hospital beds. The Washington Post. 2020 March 13. Available from: https://www.washingtonpost.com/health/2020/03/13/coronavirus-numbers-we-really-should-be-worried-about/

[8] Hick, J. L., D. Hanfling, M. K. Wynia, and A. T. Pavia. Duty to Plan: Health Care, Crisis Standards of Care, and Novel Coronavirus SARS-CoV-2. NAM Perspectives. Discussion paper. National Academy of Medicine. 2001 [cited 2-2- March 14] Washington, DC. Available from: https://doi.org/10.31478/202003b

[9] Wang, D., B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, B. Wang, H. Xiang, Z. Cheng, Y. Xiong, Y. Zhao, Y. Li, X. Wang, and Z. Peng. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA [Internet]. 2020 [cited 2020 March 14]. Available from: https://doi.org/10.1001/jama.2020.1585